In Italy, cardiovascular disease is a leading cause of mortality, morbidity, and disability. Among all cardiovascular diseases, a prominent role is played by heart failure (HF), with 600,000 people suffering from heart failure. It is estimated that the frequency of...
Implantable LVAD (Left Ventricular Assist Device) in addition to guideline directed medical therapy (GDMT) in end stage heart failure
Left ventricular assist device (LVAD) is considered an alternative to transplantationin end stage acute or chronic left ventricular congestive heart failure (HF). Use of LVAD improves the allocation of transplants alleviating the shortage of donors. The target...
Left Ventricular Assist Devices for Destination Therapy: A Health Technology Assessment
Left ventricular assist devices help keep blood flowing through the body by assisting a specific chamber in the hearts of patients with severe heart failure. A left ventricular assist device can be implanted as a last resort for patients with severe heart...
Evaluation of the evidence on the HeartMate II® and HeartWare® ventricular assist devices for the treatment of chronic end-stage heart failure
Heart failure is a complex syndrome that arises when the heart is incapable of pumping enough blood to respond to the metabolic needs of the body. Heart failure is often caused by defective contraction and relaxation of the myocardium, accompanied by elevated cardiac...
Search for
Library Categories
Full reports
Guidelines
Other
Rapid assessments
Review papers